Clinical Trial Enrollment Support

There’s More to Enrollment Than Finding Potential Participants.

Consent2Randomize can help research sites bring in potential participants, handle the follow-up and early enrollment work after someone shows interest, or both.

Your site decides what C2R handles for the study. That may include recruitment, intake, site-approved preliminary prescreening, follow-up, scheduling, documentation, and a clear handoff to your research team.

When C2R May Be Useful

Not every study needs outside enrollment support. But a new study, changing patient interest, or a shift in study activity can change what the enrollment work looks like.

Clinical research professionals collaborating at a workstation reviewing study enrollment workflow information.

A Study Is Starting

A new or upcoming study can introduce its own recruitment plan, patient communications, scheduling needs, and enrollment workflow.

Clinical research intake specialist reviewing referral documents and incoming patient interest before site handoff.

Patient Interest Is Increasing

Referrals, sponsor programs, outreach, or recruitment can change the amount and timing of patient interest reaching the site.

Clinical research coordinator reviewing enrollment workflow and study activity with site staff.

The Enrollment Work Changes

Several active studies, a new protocol, or changing study requirements can change which enrollment tasks need attention and when.

What Can C2R Handle?

The scope can be built around the study and the way your site wants the work handled.

Research enrollment professionals reviewing participant outreach and referral information.

Finding Potential Participants

Patient recruitment when additional candidate flow is needed.

Enrollment support professional responding to a potential participant inquiry and taking notes.

Responding and Following Up

Initial response, permitted follow-up, reminders, and keeping the current status clear.

Enrollment professional reviewing patient-reported intake information using a preliminary prescreening workflow.

Intake and Preliminary Prescreening

Collecting candidate-reported information and using site-approved preliminary questions.

Research staff coordinating study appointments using a shared calendar.

Scheduling and Coordination

Helping coordinate permitted appointments and next steps.

Research professionals reviewing organized documentation for handoff to the research team.

Documentation and Handoff

Recording what has happened, what is still open, and what the research team needs when it takes over.

Your Research Team Stays in Control

C2R handles only the work your site has approved. Your research team remains responsible for formal screening, final eligibility decisions, informed consent, protocol oversight, medical decisions, and randomization.

Study-Specific Support

How It Works

C2R support is defined around the study. Your site decides what it wants help with, and C2R works within that agreed scope.

Choose the Study

Start with the active or upcoming study where enrollment support may be useful.

Define What C2R Will Handle

Agree on the part of recruitment or early enrollment work C2R will support.

Work From the Agreed Scope

C2R handles the agreed work and provides the documentation and handoff defined for the study.

Experience Behind the Approach

Built from hands-on research-site enrollment experience.

C2R draws on hands-on experience supporting research-site prescreening and pre-consent workflows across sponsor-funded clinical trials, including work involving AbbVie, Astellas, Amgen, Gilead Sciences, Janssen, Myovant, Novartis, Pfizer, Regeneron, Receptos, and more.

This describes prior site-level experience and does not imply direct sponsor engagement, current affiliation, or endorsement.

Review the experience behind the C2R approach →

Have an Active or Upcoming Study?

Tell us how you expect recruitment and early enrollment to work for the study. We can look at where C2R may be useful and what your team wants to continue handling.

No PHI needed.